382 related articles for article (PubMed ID: 17107392)
1. Assessment of severity of hand eczema: discrepancies between patient- and physician-rated scores.
van Coevorden AM; van Sonderen E; Bouma J; Coenraads PJ
Br J Dermatol; 2006 Dec; 155(6):1217-22. PubMed ID: 17107392
[TBL] [Abstract][Full Text] [Related]
2. Comparison of oral psoralen-UV-A with a portable tanning unit at home vs hospital-administered bath psoralen-UV-A in patients with chronic hand eczema: an open-label randomized controlled trial of efficacy.
van Coevorden AM; Kamphof WG; van Sonderen E; Bruynzeel DP; Coenraads PJ
Arch Dermatol; 2004 Dec; 140(12):1463-6. PubMed ID: 15611423
[TBL] [Abstract][Full Text] [Related]
3. Severity of hand eczema assessed by patients and dermatologist using a photographic guide.
Hald M; Veien NK; Laurberg G; Johansen JD
Br J Dermatol; 2007 Jan; 156(1):77-80. PubMed ID: 17199570
[TBL] [Abstract][Full Text] [Related]
4. Relation between patients' and physicians' severity assessment of occupational hand eczema.
Cvetkovski RS; Jensen H; Olsen J; Johansen JD; Agner T
Br J Dermatol; 2005 Sep; 153(3):596-600. PubMed ID: 16120149
[TBL] [Abstract][Full Text] [Related]
5. Hand eczema severity and quality of life: a cross-sectional, multicentre study of hand eczema patients.
Agner T; Andersen KE; Brandao FM; Bruynzeel DP; Bruze M; Frosch P; Goncalo M; Goossens A; Le Coz CJ; Rustemeyer T; White IR; Diepgen T;
Contact Dermatitis; 2008 Jul; 59(1):43-7. PubMed ID: 18537992
[TBL] [Abstract][Full Text] [Related]
6. Clinical management decisions are related to the impact of psoriasis on patient-rated quality of life.
Katugampola RP; Hongbo Y; Finlay AY
Br J Dermatol; 2005 Jun; 152(6):1256-62. PubMed ID: 15948990
[TBL] [Abstract][Full Text] [Related]
7. Measuring atopic eczema severity visually: which variables are most important to patients?
Charman CR; Venn AJ; Williams H
Arch Dermatol; 2005 Sep; 141(9):1146-51; discussion 1151. PubMed ID: 16172312
[TBL] [Abstract][Full Text] [Related]
8. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective.
Charman CR; Venn AJ; Williams HC
Arch Dermatol; 2004 Dec; 140(12):1513-9. PubMed ID: 15611432
[TBL] [Abstract][Full Text] [Related]
9. Skin scar preconceptions must be challenged: importance of self-perception in skin scarring.
Brown BC; Moss TP; McGrouther DA; Bayat A
J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1022-9. PubMed ID: 19501559
[TBL] [Abstract][Full Text] [Related]
10. The hand eczema severity index (HECSI): a scoring system for clinical assessment of hand eczema. A study of inter- and intraobserver reliability.
Held E; Skoet R; Johansen JD; Agner T
Br J Dermatol; 2005 Feb; 152(2):302-7. PubMed ID: 15727643
[TBL] [Abstract][Full Text] [Related]
11. An audit of the impact of a consultation with a paediatric dermatology team on quality of life in infants with atopic eczema and their families: further validation of the Infants' Dermatitis Quality of Life Index and Dermatitis Family Impact score.
Beattie PE; Lewis-Jones MS
Br J Dermatol; 2006 Dec; 155(6):1249-55. PubMed ID: 17107397
[TBL] [Abstract][Full Text] [Related]
12. Measurement of patient-relevant benefits in the treatment of chronic hand eczema--a novel approach.
Blome C; Maares J; Diepgen T; Jeffrustenbach S; Augustin M
Contact Dermatitis; 2009 Jul; 61(1):39-45. PubMed ID: 19659963
[TBL] [Abstract][Full Text] [Related]
13. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
14. Medical consultations in relation to severity of hand eczema in the general population.
Hald M; Berg ND; Elberling J; Johansen JD
Br J Dermatol; 2008 Apr; 158(4):773-7. PubMed ID: 18241259
[TBL] [Abstract][Full Text] [Related]
15. Pictorial Representation of Illness and Self Measure (PRISM): A novel visual instrument to measure quality of life in dermatological inpatients.
Mühleisen B; Büchi S; Schmidhauser S; Jenewein J; French LE; Hofbauer GF
Arch Dermatol; 2009 Jul; 145(7):774-80. PubMed ID: 19620558
[TBL] [Abstract][Full Text] [Related]
16. Life quality assessment among patients with atopic eczema.
Holm EA; Wulf HC; Stegmann H; Jemec GB
Br J Dermatol; 2006 Apr; 154(4):719-25. PubMed ID: 16536816
[TBL] [Abstract][Full Text] [Related]
17. The effect of dermatology consultations in secondary care on treatment outcome and quality of life in new adult patients with atopic dermatitis.
Baron SE; Morris PK; Dye L; Fielding D; Goulden V
Br J Dermatol; 2006 May; 154(5):942-9. PubMed ID: 16634899
[TBL] [Abstract][Full Text] [Related]
18. Willingness-to-pay and quality of life in patients with vitiligo.
Radtke MA; Schäfer I; Gajur A; Langenbruch A; Augustin M
Br J Dermatol; 2009 Jul; 161(1):134-9. PubMed ID: 19298268
[TBL] [Abstract][Full Text] [Related]
19. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease.
Basra MK; Sue-Ho R; Finlay AY
Br J Dermatol; 2007 Mar; 156(3):528-38. PubMed ID: 17300244
[TBL] [Abstract][Full Text] [Related]
20. Does ad hoc quality-of-life discussion in inflammatory skin disease consultations reflect standardized patient-reported outcomes?
Davies E; Patel C; Salek MS; Finlay AY
Clin Exp Dermatol; 2008 Jan; 33(1):16-21. PubMed ID: 18076697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
